Azacitidine in Combination with Venetoclax Maintenance Post-allogeneic Hematopoietic Stem Cell Transplantation in T Cell Acute Lymphoblastic Leukemia

Azacitidine in Combination with Venetoclax Maintenance Post-allogeneic Hematopoietic Stem Cell Transplantation in T Cell Acute Lymphoblastic Leukemia

Bibliographic Details
Main Authors:	Mona Ali Hassan, Nour Moukalled, Jean El Cheikh, Ali Bazarbachi, Iman Abou Dalle
Format:	Article
Language:	English
Published:	SAABRON PRESS 2023-01-01
Series:	Clinical Hematology International
Online Access:	https://doi.org/10.1007/s44228-022-00019-1

Similar Items

Novel strategies to prevent and overcome relapse after allogeneic hematopoietic cell transplantation in acute lymphoblastic leukemia
by: Mohammad Hassan Hodroj, et al.
Published: (2023-06-01)

Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant
by: Leena T. Rahmat, et al.
Published: (2018-01-01)

Safety and Efficacy of Elective Switch from Nilotinib to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
by: Ali Ibrahim, et al.
Published: (2022-05-01)

Successful Haploidentical Hematopoietic Stem Cell Transplantation with Azacitidine and Venetoclax Maintenance Therapy for Acute Myeloid Leukemia with NUP98-RARG Gene Fusion
by: Jiaojiao Yuan, et al.
Published: (2023-03-01)

PB1806: AZACITIDINE + VENETOCLAX IN PATIENTS WITH ACUTE MYELOID LEUKEMIA, POTENTIAL CANDIDATES TO ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANT – RESULTS FROM A HOSPITAL CENTER
by: C. Barros Lima, et al.
Published: (2022-06-01)

Haploidentical stem cell transplantation with post-transplant cyclophosphamide challenges and outcome from a tertiary care center in Lebanon
by: Jean El Cheikh, et al.
Published: (2023-06-01)

Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center
by: Ziyi Hao, et al.
Published: (2024-12-01)

Venetoclax plus rituximab or obinutuzumab after allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia
by: Othman Al-Sawaf, et al.
Published: (2019-05-01)

Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation
by: Jiayu Huang, et al.
Published: (2024-07-01)

ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: Federico Lussana, et al.
Published: (2014-10-01)

Venetoclax triggers sublethal apoptotic signaling in venetoclax-resistant acute myeloid leukemia cells and induces vulnerability to PARP inhibition and azacitidine
by: Mahesh Tambe, et al.
Published: (2024-10-01)

Case report: Venetoclax plus Azacitidine in treatment of acute undifferentiated leukemia
by: Yu Cui, et al.
Published: (2024-12-01)

Radical surgery and venetoclax plus azacitidine in an octogenarian with acute myeloid leukemia
by: Florian Ramdohr, et al.
Published: (2022-12-01)

Sweet Syndrome in a Patient with Acute Leukemia on Azacitidine and Venetoclax Treatment
by: Rezmuves Maria Gabriela, et al.
Published: (2023-09-01)

Genetic Profiling in Children With Acute Lymphoblastic Leukemia Referred for Allogeneic Hematopoietic Stem Cell Transplantation
by: Kinga Kwiecinska MD, et al.
Published: (2022-02-01)

Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia
by: Amanda C. Winters, et al.
Published: (2019-10-01)

Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax
by: Lisa M. Niswander, et al.
Published: (2023-04-01)

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia
by: Ron Ram, et al.
Published: (2011-08-01)

Venetoclax in combination with chidamide and azacitidine for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia with the MLL-AF4 gene: a case report and literature review
by: Xuelian Jin, et al.
Published: (2025-01-01)

Bi- and Tri-specific antibodies in non-Hodgkin lymphoma: current data and perspectives
by: Iman Abou Dalle, et al.
Published: (2024-01-01)

Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia
by: Yimei Feng, et al.
Published: (2023-06-01)

Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center
by: Hakan Göker, et al.
Published: (2023-08-01)

P561: VIALE-T: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF VENETOCLAX IN COMBINATION WITH AZACITIDINE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
by: C. Craddock, et al.
Published: (2022-06-01)

Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
by: Leiming Xia, et al.
Published: (2023-05-01)

The Use of Voriconazole as Primary Prophylaxis for Invasive Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation: A Single Center’s Experience
by: Ali Atoui, et al.
Published: (2021-10-01)

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.
by: Vyas, P, et al.
Published: (2015)

Allogeneic stem Cell Transplantation outcome in acute Lymphoblastic Leukemia Patients
by: Kamran Alimoghaddam, et al.
Published: (2015-10-01)

Allogeneic stem Cell Transplantation outcome in acute Lymphoblastic Leukemia Patients
by: Kamran Alimoghaddam, et al.
Published: (2012-10-01)

Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML
by: Xing-yu Cao, et al.
Published: (2023-12-01)

Place of Allogeneic Hematopoietic Stem Cell Transplantation in the First Complete Remission in Ph-positive Acute Lymphoblastic Leukemia in Adults
by: K. S. Afanaseva, et al.
Published: (2023-12-01)

Clinical outcomes and early immune reconstitution in patients with acute lymphoblastic leukemia underwent allogeneic hematopoietic stem cell transplantation
by: Huiyu LI, et al.
Published: (2023-09-01)

Allogeneic Hematopoietic Stem Cell Transplantation for a BCR-FGFR1 Myeloproliferative Neoplasm Presenting as Acute Lymphoblastic Leukemia
by: Karl Haslam, et al.
Published: (2012-01-01)

Combining azole antifungals with venetoclax plus azacitidine in patients with newly diagnosed acute myeloid leukemia
by: Xushu Zhong, et al.
Published: (2024-12-01)

PB1862: VENETOCLAX AND AZACITIDINE THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE RENAL IMPAIRMENT
by: Ryosuke Naka, et al.
Published: (2023-08-01)

Azacitidine and donor lymphocyte infusion for patients with relapsed acute myeloid leukemia and myelodysplastic syndromes after allogeneic hematopoietic stem cell transplantation: A meta-analysis
by: Xuefeng Li, et al.
Published: (2022-08-01)

P1377: THE IMPACT OF THE TRAVELED DISTANCE TO THE TRANSPLANT CENTER ON THE CLINICAL OUTCOME OF ALLOGENIC BONE MARROW TRANSPLANT PATIENTS
by: J. El Cheikh, et al.
Published: (2022-06-01)

Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience
by: Dai Chihara, et al.
Published: (2022-12-01)

Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia
by: Mehmet Sezgin Pepeler, et al.
Published: (2024-12-01)

RELAPSED UBTF-TD MDS TREATED WITH VENETOCLAX AND AZACITIDINE
by: Henrik Hasle, et al.
Published: (2023-12-01)

EXPLORING THE EFFICACY OF AZACITIDINE AND VENETOCLAX COMBINATION IN TREATING ACUTE MYELOID LEUKEMIA IN CASES OF RELAPSE FOLLOWING AZACITIDINE TREATMENT AND HIGH-DOSE VITAMINS THERAPY
by: VM Sthel, et al.
Published: (2023-10-01)